Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(11 sites)

United States

Arkansas Children's Hospital, Little Rock, Arkansas

Connecticut Children's Hospital, Hartford, Connecticut

Nicklaus Children's Hospital, Miami, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

Kapiolani Medical Center for Women and Children, Honolulu, Hawaii

Cardinal Glennon Children's Medical Center, St Louis, Missouri

Duke University, Durham, North Carolina

Randall Children's Hospital, Portland, Oregon

Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey, Pennsylvania

Monroe Carrell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee

Dell Children's Blood and Cancer Center, Austin, Texas